Here's Why Sage Therapeutics Gained 48.9% in January
The pharma company reported positive results from an important phase 3 trial.
Sunday, February 10, 2019
Here's Why Sage Therapeutics Gained 48.9% in January
Here's Why Sage Therapeutics Gained 48.9% in January
The pharma company reported positive results from an important phase 3 trial.
Related Posts:
Liberty TripAdvisor Holdings Inc (LTRPA) Q1 2019 Earnings Call Transcript- Huawei is not controlled by China, executive says
- China says hopes U.S. does not underestimate its determination
- RadNet Inc (RDNT) Q1 2019 Earnings Call Transcript
- Volkswagen will use Traton proceeds to internationalize truck business: CEO
0 comments:
Post a Comment